These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 439575)

  • 1. [Effect of hypotensive treatment on the excretion of catecholamines and their metabolites in patients with essential hypertension].
    Brym E
    Kardiol Pol; 1979; 22(2):129-37. PubMed ID: 439575
    [No Abstract]   [Full Text] [Related]  

  • 2. The treatment of arterial hypertension with acebutolol. Its effect on the urinary catecholamine excretion.
    Streian C; Comşulea L; Deutsch G; Mangiuca M; Ienea A
    Med Interne; 1981; 19(3):259-63. PubMed ID: 7302505
    [No Abstract]   [Full Text] [Related]  

  • 3. [Essential arterial hypertension with elevated urinary excretion of free catecholamines. Chronobiological study].
    Trotta A; Acitelli P; Cicogna S; Di Pietro M; Spacca G; Natali G
    G Ital Cardiol; 1982; 12(11):780-4. PubMed ID: 7182217
    [No Abstract]   [Full Text] [Related]  

  • 4. [Urinary excretion of catecholamines and their metabolites in patients with essential hypertension].
    Januszewicz W; Wocial B
    Kardiol Pol; 1975; 18(2):167-72. PubMed ID: 1133891
    [No Abstract]   [Full Text] [Related]  

  • 5. [Long-term clinical study and serial determination of urinary catecholamines using the new antihypertensive agent ST-155].
    Villalpando J; Skromme D; Chávez B; Serrano P
    Arch Inst Cardiol Mex; 1968; 38(6):841-50. PubMed ID: 5711376
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of labetalol on the excretion of catecholamines and their metabolites in primary hypertension].
    Wocial B; Sznajderman M; Brym E; Cybulska I; Czerniewska E
    Pol Tyg Lek; 1981 Aug; 36(35):1337-9. PubMed ID: 7329848
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of small doses of guanfacine (Estulic Sandoz) on the lipid levels and catecholamine excretion in patients with essential hypertension.
    Balazovjech I; Skultétyová D; Mikulecký M; Kratochvíl'ová H
    Cor Vasa; 1987; 29(4 Suppl 1):46-52. PubMed ID: 3315451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the excretion of catecholamines and their metabolites in patients with essential hypertension during sodium intake restriction.
    Wocial B; Januszewicz W; Chodakowska J; Feltynowski T
    Cor Vasa; 1981; 23(3):222-8. PubMed ID: 6790225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of urinary catecholamines in cases of hypertension before and during hypotensive therapy.
    Sikka KK; Misra SS; Mital HS; Dalmia SS; Gupta KS
    Indian Heart J; 1968 Jul; 20(3):344-8. PubMed ID: 5705277
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of Effortil therapy on the urinary catecholamine excretion].
    Baltă N; Bubuianu G; Cruceanu I; Căpilnă S; Drăgulescu N
    Fiziol Norm Patol; 1973; 19(4):331-7. PubMed ID: 4741265
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of various hypotensive agents on urinary excretion of catecholamines and vanilmandelic acid].
    Woyda J; Gryglewska I
    Pol Tyg Lek; 1973 Jul; 28(30):1141-4. PubMed ID: 4732709
    [No Abstract]   [Full Text] [Related]  

  • 12. [Plasma renin activity and urinary excretion of catecholamines and their metabolites in patients with primary arterial hypertension treated with metoprolol].
    Wocial B; Januszewicz W; Sznajderman M; Cybulska I; Brym E; Czerniewska E
    Pol Tyg Lek; 1983 Apr; 38(14):439-42. PubMed ID: 6356082
    [No Abstract]   [Full Text] [Related]  

  • 13. [Urinary excretion of catecholamines and their metabolites in labile arterial hypertension].
    Coucello JA; Bicho MP; Ventura AJ
    Acta Med Port; 1983 Jan; 4(1):35-40. PubMed ID: 6823782
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of new hypotensive agent esbatal for treatment of the patients with hypertension].
    Borisenko AP
    Vrach Delo; 1967 Feb; 2():138-40. PubMed ID: 5617007
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of antihypertensive treatment on the increased beta 2-adrenoceptor density in patients with essential hypertension.
    Bono M; Cases A; Calls J; Gaya J; Jiménez W; Carretero J; Rivera F; Revert L
    Am J Hypertens; 1995 May; 8(5 Pt 1):487-93. PubMed ID: 7662225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the hypotensive effect of captopril in patients with severe and treatment-resistant arterial hypertension].
    Grajek S; Paradowski S; Kozłowska F; Gracz M
    Kardiol Pol; 1988; 31(8):515-22. PubMed ID: 3072437
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of atenolol on the excretion of catecholamines and their metabolites and dihydroxyphenylalanine (DOPA) in patients with essential hypertension].
    Wocial B; Januszewicz W; Sznajderman M; Feltynowski T
    Pol Arch Med Wewn; 1982 Mar; 67(3):87-91. PubMed ID: 6810328
    [No Abstract]   [Full Text] [Related]  

  • 18. [The hemodynamic effects of a number of new hypotensive preparations].
    Ivanov SG; Smirnov VV; Batorina MI; Pastushenko LS
    Ter Arkh; 1990; 62(1):29-32. PubMed ID: 2333612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Depin-E in the treatment of hypertensive crises in patients with essential and secondary arterial hypertension].
    Breskina TN; Demidova AB; Konoshenok GV; Chinilina IV
    Ter Arkh; 1990; 62(9):64-7. PubMed ID: 2281409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypertension, heart failure and angina pectoris. Diurnal rhythm of urinary excretion of catecholamines].
    Chmara E
    Kardiol Pol; 1992 Apr; 36(4):210-3, discussion 213-4. PubMed ID: 1640665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.